She demonstrated that SARS-CoV-2-reactive CD4+ memory T cells were present in unexposed individuals, displaying low functional avidity and multiple, highly variable cross-reactivities, e.g., towards common cold coronavirus, which were not present COVID-19 patients. This evidence concerns the gene CD4 and COVID-19.